Clinical Trial Update: Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ajmaline for the diagnosis and treatment of cardiac arrhythmias has completed, including assessments in atrial fibrillation,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Brugada Syndrome
• Ventricular Tachycardia

Drugs mentioned

• Ajmaline (ajmaline)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Atrial Fibrillation, Tachycardia, Ventricular | Phase 4 | Status: COMPLETED